Hyperfine, Inc. (NASDAQ:HYPR) Receives $1.78 Consensus Target Price from Analysts

Hyperfine, Inc. (NASDAQ:HYPR) has been given a consensus recommendation of “Hold” by the six brokerages that are currently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and three have issued a buy recommendation on the company. The average 1-year price target among brokerages that have covered the stock in the last year is $1.7833.

Several brokerages recently issued reports on HYPR. Weiss Ratings reiterated a “sell (d-)” rating on shares of Hyperfine in a research report on Friday, July 17th. BTIG Research began coverage on shares of Hyperfine in a report on Wednesday, April 29th. They set a “buy” rating and a $2.00 target price on the stock. Finally, B. Riley Financial reaffirmed a “buy” rating on shares of Hyperfine in a research note on Wednesday, May 13th.

Hyperfine Price Performance

HYPR opened at $0.95 on Friday. The stock has a market cap of $94.69 million, a P/E ratio of -2.33 and a beta of 1.40. Hyperfine has a 12 month low of $0.85 and a 12 month high of $2.22. The company has a quick ratio of 4.90, a current ratio of 5.52 and a debt-to-equity ratio of 0.38. The company has a fifty day simple moving average of $1.34 and a 200 day simple moving average of $1.26.

Hyperfine (NASDAQ:HYPR) last posted its earnings results on Tuesday, May 12th. The company reported ($0.09) earnings per share for the quarter, hitting the consensus estimate of ($0.09). Hyperfine had a negative return on equity of 98.83% and a negative net margin of 226.88%.The firm had revenue of $3.90 million for the quarter, compared to analyst estimates of $3.54 million. On average, research analysts expect that Hyperfine will post -0.34 EPS for the current year.

Institutional Investors Weigh In On Hyperfine

Several institutional investors have recently added to or reduced their stakes in HYPR. EP Wealth Advisors LLC acquired a new position in Hyperfine in the 4th quarter worth $34,000. Sanctuary Advisors LLC raised its stake in shares of Hyperfine by 130.9% in the 4th quarter. Sanctuary Advisors LLC now owns 39,938 shares of the company’s stock valued at $39,000 after purchasing an additional 22,638 shares during the period. Kathmere Capital Management LLC acquired a new stake in shares of Hyperfine in the 4th quarter valued at about $51,000. Millennium Management LLC bought a new stake in shares of Hyperfine in the fourth quarter valued at about $55,000. Finally, Cerity Partners LLC bought a new stake in shares of Hyperfine in the fourth quarter valued at about $59,000. 15.03% of the stock is owned by institutional investors.

Hyperfine Company Profile

Hyperfine, Inc (NASDAQ: HYPR) is a medical technology company focused on expanding access to advanced neuroimaging through its portable magnetic resonance imaging (MRI) system. The company’s flagship product, Swoop®, is designed to enable bedside MRI scanning in a wide range of clinical environments, including emergency departments, intensive care units and outpatient clinics. By leveraging a compact, high-performance permanent magnet and a custom-designed gradient system, Hyperfine aims to reduce the logistical and financial barriers associated with traditional, large-scale MRI installations.

The Swoop system features a lightweight, wheeled design that can be maneuvered directly to a patient’s bedside, allowing clinicians to conduct diagnostic imaging without the need to transport critically ill or immobile patients.